Fritextsökning
Innehållstyper
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
2012 blir ett politiskt år
Sakta men säkert börjar glöggdimman lätta och framför oss väntar ett nytt år. Och med det många förhoppningar och ett och annat orosmoln.
-
Framåt för Biovica
Går in i klinisk studie i USA och får 460 000 genom Horizon 2020.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Euris avnoteras
Styrelsen har beslutat att lista om bolaget på en annan handelsplats, för att minska kraven på administration.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB
Why are you going to Scanlab+Biotech Forum?
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Kjell Strandberg
2009 - ytterligare ett dystert år för Big Pharma.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Analytiker: Mer krävs från Pfizer
Astrazenecas aktie har utvecklats positivt på budrykten. Så positivt att Pfizers bud kan ses som undervärderat, enligt analytiker.
-
Danish discovery could help cardiac patients
The Danish researchers have developed a component that could make live easier forpatients with heart failure.
-
NGM vill locka fler bolag till börsen
Börsplatsen NGM antar en ny modell där noterade bolag får ta del av de intäkter som genereras på börsplatsen.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Sales Representative, Applied Biosystems
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Getinge byter vd
Aktien faller och analytiker spekulerar om problem i FDA-utredning.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.